Baird Medical Investment Holdings Limited
BDMD
$1.95
$0.052.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -360.81% | -360.81% | -1.12% | -1.12% | 85.81% |
| Total Depreciation and Amortization | 2.07% | 2.07% | -5.85% | -5.85% | 28.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10,007.10% | 10,007.10% | -0.57% | -0.57% | -88.51% |
| Change in Net Operating Assets | 111.43% | 111.43% | -4.52% | -4.52% | -222.61% |
| Cash from Operations | 19.35% | 19.35% | -41.48% | -41.48% | -715.93% |
| Capital Expenditure | 90.80% | 90.80% | -72.40% | -72.40% | 61.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 90.80% | 90.80% | -72.40% | -72.40% | 61.66% |
| Total Debt Issued | 72.81% | 72.81% | 64.55% | 64.55% | 134.36% |
| Total Debt Repaid | -240.39% | -240.39% | -59.48% | -59.48% | -33.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 618.44% | 618.44% | -69.21% | -69.21% | 89.16% |
| Cash from Financing | -50.74% | -50.74% | 55.81% | 55.81% | 897.64% |
| Foreign Exchange rate Adjustments | 1,322.00% | 1,322.00% | -341.67% | -341.67% | -244.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9,885.00% | -9,885.00% | 51.91% | 51.91% | 99.31% |